OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy
Diagnostics · 08.01.2023 · 13 (2) · 232
DOI: 10.3390/diagnostics13020232 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 08.01.2023. Verfasst von Lyvia Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Visual Sciences, State University of New York Upstate Medical University, Syracuse, NY 13210, USA. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Similar to ultrasound adapting soundwaves to depict the inner structures and tissues, optical coherence tomography (OCT) utilizes low coherence light waves to assess characteristics in the eye. Compared to the previous gold standard diagnostic imaging fluorescein angiography, OCT is a noninvasive imaging modality that generates images of ocular tissues at a rapid speed. Two commonly used iterations of OCT include spectral-domain (SD) and swept-source (SS). Each comes with different wavelengths and tissue penetration capacities. OCT angiography (OCTA) is a functional extension of the OCT. It generates a large number of pixels to capture the tissue and underlying blood flow. This allows OCTA to measure ischemia and demarcation of the vasculature in a wide range of conditions. This review focused on the study of four commonly encountered diseases involving the retina including age-related macular degeneration (AMD), diabetic retinopathy (DR), central serous chorioretinopathy (CSC), and macular telangiectasia (MacTel). Modern imaging techniques including SD-OCT, TD-OCT, SS-OCT, and OCTA assist with understanding the disease pathogenesis and natural history of disease progression, in addition to routine diagnosis and management in the clinical setting. Finally, this review compares each imaging technique’s limitations and potential refinements.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology & Visual Sciences, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
- Leiden University Medical Center, 2333 Leiden, The Netherlands.
- Ophthalmology Department, San Raffaele University Hospital, 20132 Milan, Italy.
- Ophthalmology Unit, Department NESMOS, S. Andrea Hospital, University of Rome "La Sapienza", 00189 Rome, Italy.
- Retina-Vitreous Surgeons of Central New York, Liverpool, NY 13088, USA.
ORCID-Profile: Elon H C Van Dijk, Enrico Borrelli, Serena Fragiotta, Mark P Breazzano
Zitieren
APA
Zhang, L., Van Dijk, E. H. C., Borrelli, E., Fragiotta, S., & Breazzano, M. P. (2023). OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy. Diagnostics, 13(2), 232. https://doi.org/10.3390/diagnostics13020232
Vancouver
Zhang L, Van Dijk EHC, Borrelli E, Fragiotta S, Breazzano MP. OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy. Diagnostics. 2023;13(2):232. doi:10.3390/diagnostics13020232
BibTeX
@article{Zhang2023,
author = {Zhang, Lyvia and Van Dijk, Elon H C and Borrelli, Enrico and Fragiotta, Serena and Breazzano, Mark P},
title = {OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {2},
pages = {232},
doi = {10.3390/diagnostics13020232}
}
EUVIMED